Advertisement
Singapore markets closed
  • Straits Times Index

    3,314.14
    +8.12 (+0.25%)
     
  • S&P 500

    5,464.62
    -8.55 (-0.16%)
     
  • Dow

    39,150.33
    +15.53 (+0.04%)
     
  • Nasdaq

    17,689.36
    -32.24 (-0.18%)
     
  • Bitcoin USD

    60,900.32
    -3,356.92 (-5.22%)
     
  • CMC Crypto 200

    1,261.29
    -48.43 (-3.70%)
     
  • FTSE 100

    8,281.12
    +43.40 (+0.53%)
     
  • Gold

    2,337.50
    +6.30 (+0.27%)
     
  • Crude Oil

    80.90
    +0.17 (+0.21%)
     
  • 10-Yr Bond

    4.2570
    +0.0030 (+0.07%)
     
  • Nikkei

    38,804.65
    +208.18 (+0.54%)
     
  • Hang Seng

    18,027.71
    -0.81 (-0.00%)
     
  • FTSE Bursa Malaysia

    1,589.66
    -0.71 (-0.04%)
     
  • Jakarta Composite Index

    6,889.17
    +9.19 (+0.13%)
     
  • PSE Index

    6,272.46
    +113.98 (+1.85%)
     

Alkermes to Participate in Two Upcoming Investor Conferences

DUBLIN, May 29, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chat presentations at two upcoming investor conferences.

Jefferies Healthcare Conference
Date/Time: Thursday, June 6, 2024 at 1:30 p.m. EDT (6:30 p.m. BST)

Goldman Sachs 45th Annual Global Healthcare Conference
Date/Time: Tuesday, June 11, 2024 at 10:40 a.m. EDT (3:40 p.m. BST)

The live webcasts may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

About Alkermes plc
Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for neurological disorders, including narcolepsy. Headquartered in Ireland, Alkermes also has a corporate office and research and development center in Massachusetts and a manufacturing facility in Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

ADVERTISEMENT

Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402

Alkermes plc Logo (PRNewsfoto/Alkermes plc)
Alkermes plc Logo (PRNewsfoto/Alkermes plc)

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/alkermes-to-participate-in-two-upcoming-investor-conferences-302158279.html

SOURCE Alkermes plc